Literature DB >> 34038115

Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Daniel W Binzel1, Xin Li1, Nicolas Burns1, Eshan Khan2, Wen-Jui Lee3, Li-Ching Chen3, Satheesh Ellipilli1, Wayne Miles2, Yuan Soon Ho3, Peixuan Guo1.   

Abstract

RNA nanotechnology is the bottom-up self-assembly of nanometer-scale architectures, resembling LEGOs, composed mainly of RNA. The ideal building material should be (1) versatile and controllable in shape and stoichiometry, (2) spontaneously self-assemble, and (3) thermodynamically, chemically, and enzymatically stable with a long shelf life. RNA building blocks exhibit each of the above. RNA is a polynucleic acid, making it a polymer, and its negative-charge prevents nonspecific binding to negatively charged cell membranes. The thermostability makes it suitable for logic gates, resistive memory, sensor set-ups, and NEM devices. RNA can be designed and manipulated with a level of simplicity of DNA while displaying versatile structure and enzyme activity of proteins. RNA can fold into single-stranded loops or bulges to serve as mounting dovetails for intermolecular or domain interactions without external linking dowels. RNA nanoparticles display rubber- and amoeba-like properties and are stretchable and shrinkable through multiple repeats, leading to enhanced tumor targeting and fast renal excretion to reduce toxicities. It was predicted in 2014 that RNA would be the third milestone in pharmaceutical drug development. The recent approval of several RNA drugs and COVID-19 mRNA vaccines by FDA suggests that this milestone is being realized. Here, we review the unique properties of RNA nanotechnology, summarize its recent advancements, describe its distinct attributes inside or outside the body and discuss potential applications in nanotechnology, medicine, and material science.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34038115      PMCID: PMC8312718          DOI: 10.1021/acs.chemrev.1c00009

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   72.087


  581 in total

1.  Kinetics and thermodynamics of DNA, RNA, and hybrid duplex formation.

Authors:  Brittany Rauzan; Elizabeth McMichael; Rachel Cave; Lesley R Sevcik; Kara Ostrosky; Elisabeth Whitman; Rachel Stegemann; Audra L Sinclair; Martin J Serra; Alice A Deckert
Journal:  Biochemistry       Date:  2013-01-28       Impact factor: 3.162

Review 2.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

Review 3.  Drug targeting strategies in cancer treatment: an overview.

Authors:  J L Arias
Journal:  Mini Rev Med Chem       Date:  2011-01       Impact factor: 3.862

4.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.

Authors:  Xin Chen; Ang Li; Bao-Fa Sun; Ying Yang; Ya-Nan Han; Xun Yuan; Ri-Xin Chen; Wen-Su Wei; Yanchao Liu; Chun-Chun Gao; Yu-Sheng Chen; Mengmeng Zhang; Xiao-Dan Ma; Zhuo-Wei Liu; Jun-Hang Luo; Cong Lyu; Hai-Lin Wang; Jinbiao Ma; Yong-Liang Zhao; Fang-Jian Zhou; Ying Huang; Dan Xie; Yun-Gui Yang
Journal:  Nat Cell Biol       Date:  2019-07-29       Impact factor: 28.824

Review 5.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.

Authors:  Ajay Kumar Gupta; Mona Gupta
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

6.  In vivo activity of nuclease-resistant siRNAs.

Authors:  Juliana M Layzer; Anton P McCaffrey; Alice K Tanner; Zan Huang; Mark A Kay; Bruce A Sullenger
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

7.  Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization.

Authors:  Na-Kyung Ryoo; Jihwang Lee; Hyunjoo Lee; Hye Kyoung Hong; Hyejin Kim; Jong Bum Lee; Se Joon Woo; Kyu Hyung Park; Hyuncheol Kim
Journal:  Nanoscale       Date:  2017-10-19       Impact factor: 7.790

8.  RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.

Authors:  Tae Jin Lee; Farzin Haque; Dan Shu; Ji Young Yoo; Hui Li; Robert A Yokel; Craig Horbinski; Tae Hyong Kim; Sung-Hak Kim; Chang-Hyuk Kwon; Ichiro Nakano; Balveen Kaur; Peixuan Guo; Carlo M Croce
Journal:  Oncotarget       Date:  2015-06-20

9.  2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.

Authors:  Wen Shen; Xue-Hai Liang; Hong Sun; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2015-04-08       Impact factor: 16.971

10.  Folding behavior of a T-shaped, ribosome-binding translation enhancer implicated in a wide-spread conformational switch.

Authors:  My-Tra Le; Wojciech K Kasprzak; Taejin Kim; Feng Gao; Megan Yl Young; Xuefeng Yuan; Bruce A Shapiro; Joonil Seog; Anne E Simon
Journal:  Elife       Date:  2017-02-13       Impact factor: 8.140

View more
  8 in total

1.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

Review 2.  The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.

Authors:  Xin Li; Abhjeet S Bhullar; Daniel W Binzel; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2022-05-05       Impact factor: 17.873

3.  VfoldMCPX: predicting multistrand RNA complexes.

Authors:  Sicheng Zhang; Yi Cheng; Peixuan Guo; Shi-Jie Chen
Journal:  RNA       Date:  2022-01-20       Impact factor: 4.942

Review 4.  Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.

Authors:  Kirill A Afonin; Marina A Dobrovolskaia; Weina Ke; Piotr Grodzinski; Mark Bathe
Journal:  Adv Drug Deliv Rev       Date:  2021-12-13       Impact factor: 17.873

Review 5.  NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).

Authors:  Zhaomu Zeng; Yueyue Chen; Xiuchao Geng; Yuhao Zhang; Xichao Wen; Qingyu Yan; Tingting Wang; Chen Ling; Yan Xu; Junchao Duan; Kebin Zheng; Zhiwei Sun
Journal:  Int J Oncol       Date:  2022-05-04       Impact factor: 5.884

6.  Rational design of self-assembled RNA nanostructures for HIV-1 virus assembly blockade.

Authors:  Na Qu; Yachen Ying; Jinshan Qin; Antony K Chen
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

7.  Mg2+ Ions Regulating 3WJ-PRNA to Construct Controllable RNA Nanoparticle Drug Delivery Platforms.

Authors:  Le Chen; Jingyuan Li
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

Review 8.  Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management.

Authors:  Rabia Arshad; Iqra Fatima; Saman Sargazi; Abbas Rahdar; Milad Karamzadeh-Jahromi; Sadanand Pandey; Ana M Díez-Pascual; Muhammad Bilal
Journal:  Nanomaterials (Basel)       Date:  2021-12-08       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.